Search results
Results from the WOW.Com Content Network
Legal cannabis (marijuana) product. Overconsumption and reliance could lead to cannabis-induced amotivational syndrome. The term amotivational syndrome was first devised to understand and explain the diminished drive and desire to work or compete among the population of youth who are frequent consumers of cannabis and has since been researched through various methodological studies with this ...
In early research of depression in children, there was debate as to whether or not children could clinically fit the criteria for major depressive disorder. [67] However, since the 1970s, it has been accepted among the psychological community that depression in children can be clinically significant. [67]
A 2017 review suggests that cannabis has been shown to improve the mood of depression-diagnosed patients. [12] This is indicative of a longitudinal relationship between cannabis reduction and improvements in anxiety and depression. Anxiety and depression have been found to increase susceptibility to marijuana use. [52]
As of 2022, psilocybin is the most commonly researched psychedelic due to its safety and low potential for abuse and dependence. [2] Clinical trials are being conducted at universities and there is evidence confirming the use of psilocybin in the treatment of depression, post-traumatic stress disorder (PTSD) and end of life anxiety.
The strains provided at these regulated stores are often cleaner and safer than drugs purchased from a non-regulated provider.” Wellness, parenting, body image and more: Get to know the who ...
Psychotic depression persisting for more than a year following benzodiazepine withdrawal has been documented in the medical literature. The patient had no prior psychiatric history. The symptoms reported in the patient included, major depressive disorder with psychotic features, including persistent depressed mood, poor concentration, decreased ...
Clinical trials, including both open-label trials and double-blind randomized controlled trials, have found that single doses of psilocybin produce rapid and long-lasting antidepressant effects outperforming placebo in people with major depressive disorder and treatment-resistant depression. [206]
The following diagnostic systems and rating scales are used in psychiatry and clinical psychology.This list is by no means exhaustive or complete. For instance, in the category of depression, there are over two dozen depression rating scales that have been developed in the past eighty years.